Cargando…

Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients

Background: Eltrombopag (EPAG) is an oral thrombopoietin receptor agonist, approved for refractory primary immune thrombocytopenia (ITP) in pediatric patients. In two pediatric RCTs, EPAG led to an improvement of platelet counts and a reduction in bleeding severity. However, a significant number of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dionisi, Marco, Cairoli, Sara, Simeoli, Raffaele, De Gennaro, Francesca, Paganelli, Valeria, Carta, Roberto, Rossi, Francesca, Dionisi-Vici, Carlo, Palumbo, Giuseppe, Goffredo, Bianca Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685423/ https://www.ncbi.nlm.nih.gov/pubmed/34938187 http://dx.doi.org/10.3389/fphar.2021.772873

Ejemplares similares

Use of Antibiotics in Preterm Newborns
por: Simeoli, Raffaele, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with KCNT1 Genetic Variants
por: Ferretti, Alessandro, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series
por: Tortora, Francesca, et al.
Publicado: (2022)

Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age
por: De Rose, Domenico Umberto, et al.
Publicado: (2020)

Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia
por: Di Paola, Alessandra, et al.
Publicado: (2020)

Editorial: Therapeutic drug monitoring (TDM): a useful tool for pediatric pharmacology applied to routine clinical practice, Volume II
por: Simeoli, Raffaele
Publicado: (2023)

Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
por: Giordano, Paola, et al.
Publicado: (2020)

Exploring the Potential of Eltrombopag: Room for More?
por: Tarantini, Francesco, et al.
Publicado: (2022)

Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report
por: Abdelmahmuod, Elabbass A., et al.
Publicado: (2021)

PB2311: LOW-DOSE PREDNISON AND ELTROMBOPAG COMBINATION AS FRONTLINE TREATMENT IN NEWLY DIAGNOSED ITP PATIENTS
por: Liu, S.-Y., et al.
Publicado: (2022)

The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience
por: Yassin, Mohamed A, et al.
Publicado: (2022)

Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia
por: Argenziano, Maura, et al.
Publicado: (2021)

Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells
por: Di Paola, Alessandra, et al.
Publicado: (2021)

Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice
por: Simeoli, Raffaele, et al.
Publicado: (2022)

Hypoglycaemia Metabolic Gene Panel Testing
por: Maiorana, Arianna, et al.
Publicado: (2022)

The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2023)

Plasma Metabolomics Identifies the Dysregulated Metabolic Profile of Primary Immune Thrombocytopenia (ITP) Based on GC-MS
por: Zhang, Ziyan, et al.
Publicado: (2022)

Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol
por: Shimano, Kristin A, et al.
Publicado: (2021)

An ITP workbook
por: Kalman, J A
Publicado: (1986)

Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China
por: Zuo, Wei, et al.
Publicado: (2020)

Eltrombopag in long‐term management of pediatric thrombocytopenia
por: Shah, Sanjay J., et al.
Publicado: (2018)

Analysis of LPI-causing mutations on y+LAT1 function and localization
por: Rotoli, Bianca Maria, et al.
Publicado: (2019)

Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis
por: Punzo, Francesca, et al.
Publicado: (2018)

P1639: UTILITY OF NEXT GENERATION SEQUENCING TECHNIQUES TO EVALUATE POSSIBLE CAUSES OF REFRACTORINESS TO TREATMENT WITH ELTROMBOPAG IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN SPAIN.
por: Gonzalez-Lopez, T. J., et al.
Publicado: (2022)

Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders
por: Maiorana, Arianna, et al.
Publicado: (2023)

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016)

ITP Conference on High T
por: Collective
Publicado: (2000)

Lenalidomide-Associated ITP
por: Herold, Christina I., et al.
Publicado: (2011)

Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP
por: Bianchi, Simona, et al.
Publicado: (2022)

Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric Patients
por: Meibohm, Bernd
Publicado: (2022)

Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
por: Maximova, Natalia, et al.
Publicado: (2022)

P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS
por: Ghanima, W., et al.
Publicado: (2022)

P1632: PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP) TREATED WITH TPO-R AGONISTS (TPO-RA): ELTROMBOPAG (EPAG) AND ROMIPLOSTIM (ROMI) - THE PEPITE STUDY
por: Chèze, S., et al.
Publicado: (2022)

PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
por: Kolodny, Scott, et al.
Publicado: (2023)

Population Pharmacokinetics of Lithium in Young Pediatric Patients With Intellectual Disability
por: Yuan, Junying, et al.
Publicado: (2021)

Impact of Continuous Kidney Replacement Therapy and Hemoadsorption with CytoSorb on Antimicrobial Drug Removal in Critically Ill Children with Septic Shock: A Single-Center Prospective Study on a Pediatric Cohort
por: Bottari, Gabriella, et al.
Publicado: (2023)

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
por: Lee, Eun-Ju, et al.
Publicado: (2022)

Renal Mitochondrial Cytopathies
por: Emma, Francesco, et al.
Publicado: (2011)

Safety of vaccines administration in hereditary fructose intolerance
por: Maiorana, Arianna, et al.
Publicado: (2020)

Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI
por: Massese, Miriam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84fk5arrsab9d8vfc12n9jhc2a